And the defibrillator market, once a steadysource of growth, has been stagnant, acting like a millstone for Boston Scientific, which snagged Guidant, and rival Medtronic.
According to testimony, Enron's ex-Chairman Lay and ex-Chief Executive Skilling had repeatedly portrayed the division as a steadysource of predictable growth--as opposed to a high-yield and potentially risky business.